Grifols Net Income 2012-2019 | GRFS

Grifols annual/quarterly net income history and growth rate from 2012 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Grifols net income for the quarter ending March 31, 2019 was $M, a 100% decline year-over-year.
  • Grifols net income for the twelve months ending March 31, 2019 was $0.510B, a 15.44% decline year-over-year.
  • Grifols annual net income for 2018 was $0.705B, a 5.93% decline from 2017.
  • Grifols annual net income for 2017 was $0.749B, a 24.1% increase from 2016.
  • Grifols annual net income for 2016 was $0.604B, a 2.15% increase from 2015.
Grifols Annual Net Income
(Millions of US $)
2018 $705
2017 $749
2016 $604
2015 $591
2014 $621
2013 $454
2012 $328
2011 $70
Grifols Quarterly Net Income
(Millions of US $)
Q1 2019 $
Q2 2018 $209
Q2 2017 $158
Q1 2017 $143
Q4 2016 $150
Q3 2016 $158
Q2 2016 $157
Q1 2016 $138
Q4 2015 $144
Q3 2015 $156
Q2 2015 $147
Q1 2015 $145
Q4 2014 $149
Q3 2014 $151
Q2 2014 $139
Q1 2014 $168
Q4 2013 $104
Q3 2013 $112
Q2 2013 $121
Q1 2013 $118
Q4 2012 $76
Q3 2012 $80
Q2 2012 $85
Q1 2012 $87
Q4 2011 $9
Q3 2011 $35
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.700B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.237B 34.65
Astellas Pharma (ALPMY) Japan $28.255B 13.85
Takeda Pharmaceutical (TAK) Japan $27.794B 8.16
Eisai (ESALY) Japan $16.077B 27.64
UCB SA (UCBJF) Belgium $15.866B 0.00
Merck KGaA (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.629B 0.00
Sage Therapeutics (SAGE) United States $9.716B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $9.194B 20.10
Neurocrine Biosciences (NBIX) United States $7.823B 0.00
Catalent (CTLT) United States $7.787B 31.25
Jazz Pharmaceuticals (JAZZ) Ireland $7.540B 10.34
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.878B 9.58
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ Unsponsored ADR (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.944B 17.38
Evotec AG (EVTCY) Germany $4.268B 45.82
Tilray (TLRY) Canada $4.214B 0.00
FibroGen (FGEN) United States $3.929B 0.00
United Therapeutics (UTHR) United States $3.351B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.195B 11.47
Arrowhead Pharmaceuticals (ARWR) United States $2.574B 387.86
PTC Therapeutics (PTCT) United States $2.510B 0.00
Xencor (XNCR) United States $2.499B 68.21
Zogenix (ZGNX) United States $1.999B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.705B 82.56
Enanta Pharmaceuticals (ENTA) United States $1.669B 22.80
Tricida (TCDA) United States $1.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.618B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.558B 0.00
Heron Therapeutics (HRTX) United States $1.467B 0.00
USANA Health Sciences (USNA) United States $1.394B 12.12
Turning Point Therapeutics (TPTX) United States $1.322B 0.00
Esperion Therapeutics (ESPR) United States $1.225B 0.00
Corcept Therapeutics (CORT) United States $1.220B 17.41
ArQule (ARQL) United States $1.211B 0.00
Aerie Pharmaceuticals (AERI) United States $1.202B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.105B 3.98
Radius Health (RDUS) United States $1.024B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.973B 0.00
Odonate Therapeutics (ODT) United States $0.962B 0.00
Endo (ENDP) Ireland $0.927B 1.49
Spectrum Pharmaceuticals (SPPI) United States $0.904B 0.00
Concordia (CXRXF) Canada $0.729B 0.00
Organogenesis Holdings (ORGO) United States $0.707B 0.00
Aptorum Group (APM) China $0.672B 0.00
Vectura Group (VEGPF) $0.628B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.594B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.581B 0.00
GlycoMimetics (GLYC) United States $0.547B 0.00
Translate Bio (TBIO) United States $0.517B 0.00
Akebia Therapeutics (AKBA) United States $0.496B 0.00
ChemoCentryx (CCXI) United States $0.493B 0.00
Karyopharm Therapeutics (KPTI) United States $0.489B 0.00
Dova Pharmaceuticals (DOVA) United States $0.480B 0.00
Dermira (DERM) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.464B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.458B 23.09
Indivior (INVVY) United States $0.434B 1.57
Corbus Pharmaceuticals Holdings (CRBP) United States $0.426B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.421B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 0.00
CV Sciences (CVSI) United States $0.416B 0.00
Flexion Therapeutics (FLXN) United States $0.410B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.400B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Collegium Pharmaceutical (COLL) United States $0.381B 0.00
Innate Pharma SA (IPHYF) France $0.366B 0.00
ImmunoGen (IMGN) United States $0.365B 0.00
Harpoon Therapeutics (HARP) United States $0.365B 0.00
CannTrust Holdings (CTST) Canada $0.364B 0.00
OptiNose (OPTN) United States $0.330B 0.00
Forty Seven (FTSV) United States $0.322B 0.00
Xeris Pharmaceuticals (XERS) United States $0.321B 0.00
TCR2 Therapeutics (TCRR) United States $0.311B 0.00
CASI Pharmaceuticals (CASI) United States $0.303B 0.00
KalVista Pharmaceuticals (KALV) United States $0.299B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.283B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.260B 0.00
Minerva Neurosciences (NERV) United States $0.254B 0.00
Aratana Therapeutics (PETX) United States $0.244B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.241B 0.00
Bio Blast Pharma (ENLV) Israel $0.233B 0.00
Lannett Co Inc (LCI) United States $0.228B 2.22
Recro Pharma (REPH) United States $0.223B 0.00
Ocular Therapeutix (OCUL) United States $0.221B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.219B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.201B 0.00
IMV INC (IMV) Canada $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 54.69
Calithera Biosciences (CALA) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.161B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.160B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
Aldeyra Therapeutics (ALDX) United States $0.154B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
MEI Pharma (MEIP) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.143B 0.00
Tyme Technologies (TYME) United States $0.140B 0.00
Majesco Entertainment (PTE) United States $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.128B 0.00
Neon Therapeutics (NTGN) United States $0.122B 0.00
DURECT (DRRX) United States $0.107B 0.00
Aquestive Therapeutics (AQST) United States $0.107B 0.00
Avenue Therapeutics (ATXI) United States $0.103B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
Heatwurx (PCSA) United States $0.095B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.093B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 0.00
Capnia (SLNO) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 63.00
MediWound (MDWD) Israel $0.087B 0.00
Genocea Biosciences (GNCA) United States $0.087B 0.00
Adherex Technologies (FENC) United States $0.085B 0.00
Natural Alternatives (NAII) United States $0.084B 8.40
Avadel Pharmaceuticals (AVDL) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Cardiome Pharma (CORV) Canada $0.082B 0.00
Golden Dragon Holding (CPMD) Canada $0.081B 0.00
China SXT Pharmaceuticals (SXTC) China $0.079B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Novan (NOVN) United States $0.074B 0.00
Neos Therapeutics (NEOS) United States $0.072B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Relmada Therapeutics (RLMD) United States $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
IntelGenx Technologies (IGXT) Canada $0.047B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
KemPharm (KMPH) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Zafgen (ZFGN) United States $0.044B 0.00
Nuvilex (PMCB) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
BioLineRx (BLRX) Israel $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.023B 0.00
Pain Therapeutics (SAVA) United States $0.023B 0.00
GTx (ONCT) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 1.49
Cyanotech (CYAN) United States $0.016B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.015B 0.00
Shineco (TYHT) China $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
PreveCeutical Medical (PRVCF) $0.014B 0.00
Bioasis Technologies (BIOAF) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.011B 0.00
Xenetic Biosciences (XBIO) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 1.72
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Integrated BioPharma (INBP) United States $0.009B 3.75
NEUROVIVE (NEVPF) Sweden $0.008B 0.00
Praxsyn (PXYN) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Nuvo Research (NRIFF) Canada $0.006B 0.00
BIOCARDIA INC (BCDA) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
Intellipharmaceutics (IPCIF) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Innovus Pharmaceuticals (INNV) United States $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Polydex Pharmaceuticals (POLXF) Canada $0.004B 10.50
ULURU (ULUR) United States $0.003B 0.00
Cannabis Therapy (PKPH) United States $0.003B 0.00
Aradigm (ARDMQ) United States $0.002B 0.00
Critical Outcome Technologies (COTQF) United States $0.002B 0.00
Biostar Pharmaceuticals (BSPM) China $0.001B 0.00
HST Global (HSTC) United States $0.001B 0.00
MabVax Therapeutics Holdings (MBVXQ) United States $0.000B 0.00
Alseres Pharmaceuticals (ALSE) United States $0.000B 0.00
Inspyr Therapeutics (NSPX) United States $0.000B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Acusphere (ACUS) United States $0.000B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.000B 0.00
American Oriental Bioengineering (AOBI) China $0.000B 0.00
Aeolus Pharmaceuticals (AOLS) United States $0.000B 0.00
Aoxing Pharmaceutical (AOXG) China $0.000B 0.00
AXM Pharma (AXMP) United States $0.000B 0.00
Lotus Pharmaceuticals (LTUS) China $0.000B 0.00
Neurobiological Technologies (NTII) United States $0.000B 0.00
Poniard Pharmaceuticals (PARD) United States $0.000B 0.00
Pharmos (PARS) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
Pivotal Therapeutics (PVTTF) $0.000B 0.00
Rock Creek Pharmaceuticals (RCPIQ) United States $0.000B 0.00
Skinvisible (SKVI) United States $0.000B 0.00
Synovics Pharmaceuticals (SYVC) United States $0.000B 0.00
Tibet Pharmaceuticals (TBET) China $0.000B 0.00
Tianyin Pharmaceutical (TPIY) China $0.000B 0.00
VioQuest Pharmaceuticals (VOQP) United States $0.000B 0.00